CUR Press Releases | Neuralstem, Inc. Common Stock Stock - Yahoo! Finance

Wed, May 22, 2013, 12:37PM EDT - U.S. Markets close in 3 hrs 23 mins

Dow

0.46% Nasdaq

0.21%

More On CUR

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Neuralstem, Inc. (CUR)

-NYSE MKT

1.45 0.02(1.39%) 12:34PM EDT - Nasdaq Real Time Price

Add to Portfolio

Press Releases

Get Press Releases for:

Monday, May 20, 2013

Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In RomaniaPR Newswire( (Mon, May 20)

Thursday, May 16, 2013

Neuralstem CEO, Richard Garr, To Present At Annual World Stem Cells And Regenerative Medicine Congress In LondonPR Newswire( (Thu, May 16)

Monday, May 13, 2013

Neuralstem Principal Investigator, Dr. Eva Feldman, Presents Phase I ALS Trial Data At The Romanian Neurological Society CongressPR Newswire( (Mon, May 13)

Friday, May 10, 2013

Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical UpdatePR Newswire( (Fri, May 10)

Wednesday, May 8, 2013

Neuralstem ALS Trial Investigator And Patient On Sirius XMPR Newswire( (Wed, May 8)

Monday, April 29, 2013

Neuralstem ALS Trial Data Presented At The American Association Of Neurological Surgeons Annual MeetingPR Newswire( (Mon, Apr 29)

Wednesday, April 24, 2013

Neuralstem And The National Football League Alumni Association Announce Initiative On Brain Injury TreatmentPR Newswire( (Wed, Apr 24)

Monday, April 22, 2013

FDA Approves Neuralstem To Treat Final Cohort In NSI-189 Phase Ib Trial In Major Depressive DisorderPR Newswire( (Mon, Apr 22)

Thursday, April 18, 2013

Neuralstem CEO, Richard Garr, To Participate In Traumatic Brain Injury Panel At BIO International ConventionPR Newswire( (Thu, Apr 18)

Wednesday, April 17, 2013

Neuralstem Receives FDA Approval To Commence Phase II Stem Cell Trial In Amytrophic Lateral SclerosisPR Newswire( (Wed, Apr 17)

Friday, April 5, 2013

Neuralstem Receives Notice Of Allowance Of Patent Covering Use Of Stem Cells To Treat Amyotrophic Lateral SclerosisPR Newswire( (Fri, Apr 5)

Monday, March 25, 2013

Neuralstem Secures $8 Million In Debt Financing From HerculesPR Newswire( (Mon, Mar 25)

Wednesday, March 20, 2013

Neuralstem President and CEO, Richard Garr Publishes New Blog Post Titled ''The Best Thing About the Future is that It Comes One Day at a Time''Accesswire( (Wed, Mar 20)